BIONTECH SE-ADR(NASDAQ:BNTX) stock News

BNTX Latest News, Press Relases and Analysis

All

Press Releases

10 days ago - By: Chartmill - Mentions: FIG PFE ADBE ORCL ...

Oracle Retreats, Fed Rate Cut Looms, and Vaccine Politics Shake Pharma Stocks

2 days ago - By: BioNTech SE

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

2 days ago - By: BioNTech SE

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

2 days ago - By: BioNTech SE

BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Ausgabe der „Innovation Series“

2 days ago - By: The Motley Fool - Mentions: JPM PFE

Why BioNTech Stock Bumped Higher Today

5 days ago - By: Investor's Business Daily - Mentions: PFE MRNA NVAX

CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids

6 days ago - By: Investor's Business Daily - Mentions: PFE MRNA NVAX

The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut

8 days ago - By: Zacks Investment Research - Mentions: PFE MRNA NVAX

MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response

9 days ago - By: Benzinga - Mentions: PFE MRNA

Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax

9 days ago - By: Yahoo Finance - Mentions: BMY

Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction

9 days ago - By: Yahoo Finance - Mentions: PFE

Phase 3 Data Supports FDA Approval for Pfizer Inc. (PFE)’s 2025–2026 COVID-19 Vaccine

12 days ago - By: The Motley Fool - Mentions: PFE

Why BioNTech Stock Sank by More Than 7% Today

14 days ago - By: Investor's Business Daily - Mentions: PFE NYT LLY ZLAB ...

China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order

16 days ago - By: Zacks Investment Research - Mentions: BMY MRK SMMT

SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study

17 days ago - By: BioNTech SE

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

17 days ago - By: BioNTech SE

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

17 days ago - By: BioNTech SE

Erste Zwischenergebnisse aus BioNTechs und BMS‘ globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig (BNT327/BMS986545) zeigen ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem kleinzelligem Lungenkrebs

17 days ago - By: Stocktwits - Mentions: PFE

Pfizer, BioNTech’s Updated COVID-19 Vaccine Shows Robust Immune Response In Late-Stage Study – More Details Inside

17 days ago - By: Investor's Business Daily - Mentions: PFE SMMT MRK

Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch

17 days ago - By: Benzinga

What Analysts Are Saying About BioNTech Stock

17 days ago - By: Pfizer Inc. - Mentions: PFE

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

20 days ago - By: Investor's Business Daily - Mentions: PFE MRNA NVAX

Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?

20 days ago - By: Investor's Business Daily

BioNTech Surges 10% On Promising Test Results For Its Cancer Smart Bomb

20 days ago - By: Stocktwits - Mentions: APIE TCAF

Why Did BioNTech Stock Surge 10% Pre-Market Today?

a month ago - By: Yahoo Finance - Mentions: BMY

BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal

a month ago - By: Stocktwits - Mentions: PFE MRNA

Pfizer, BioNTech Get FDA Clearance For Updated Covid Vaccine In Senior Adults And Younger At-Risk Population

a month ago - By: Investor's Business Daily - Mentions: PFE MRNA NVAX

BIONTECH SE-ADR (BNTX) Stock News

BNTX Latest News, Press Relases and Analysis

Oracle Retreats, Fed Rate Cut Looms, and Vaccine Politics Shake Pharma Stocks

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

BioNTech veranstaltet am 1. Oktober 2025 zweiten „AI Day“ als eine Ausgabe der „Innovation Series“

Why BioNTech Stock Bumped Higher Today

CDC Ends Universal Covid Vaccine Recommendation; Moderna Skids

The Battle Over Covid Vaccines Hits A Fever Pitch As RFK-Picked Panel Makes Its Debut

MRNA Stock Rises as Updated COVID-19 Jab Shows Strong Immune Response

Moderna Reports 8-Fold Jump In Antibodies With Updated Spikevax

Bristol-Myers Squibb Company (BMY)-BioNTech Lung Cancer Therapy Shows 76% Tumor Reduction

Phase 3 Data Supports FDA Approval for Pfizer Inc. (PFE)’s 2025–2026 COVID-19 Vaccine

Why BioNTech Stock Sank by More Than 7% Today

China-Tied Biotechs Zai Labs, BeOne Plunge On Rumored Executive Order

SMMT Stock Plummets 25% on Regional Data Differences in NSCLC Study

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Erste Zwischenergebnisse aus BioNTechs und BMS‘ globaler Phase-2-Studie mit bispezifischem PD-L1xVEGF-A-Antikörperkandidat Pumitamig (BNT327/BMS986545) zeigen ermutigende Anti-Tumor-Aktivität bei fortgeschrittenem kleinzelligem Lungenkrebs

Pfizer, BioNTech’s Updated COVID-19 Vaccine Shows Robust Immune Response In Late-Stage Study – More Details Inside

Summit Therapeutics Crashes After Failing To Deliver Another Merck-Walloping Punch

What Analysts Are Saying About BioNTech Stock

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

Shots Fired! After RFK Jr.'s Senate Grilling, Will Pfizer, Moderna Survive The Battle In D.C.?

BioNTech Surges 10% On Promising Test Results For Its Cancer Smart Bomb

Why Did BioNTech Stock Surge 10% Pre-Market Today?

BioNTech SE (BNTX) Teams Up with BMS in $11B Cancer Deal

Pfizer, BioNTech Get FDA Clearance For Updated Covid Vaccine In Senior Adults And Younger At-Risk Population

RFK Jr. Makes Good On Promise To End Covid Vaccine Mandate. BioNTech Tumbles.